insights_auto
Kwa nini EDIT imepungua kwa 2.41%?
Fahamu zaidichevron_right
EDIT:NASDAQ
Editas Medicine Inc
US$ 1.82
arrow_downward
-2.41%(-0.045) Siku 1
US$ 1.92
arrow_upward
+5.21% (+0.095)bedtimeBaada ya saa
Imefungwa: 17 Nov, 16:00:01 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya EDIT...
Fungua
US$ 1.90
Juu
US$ 1.94
Chini
US$ 1.82
Mtaji wa soko
281.67M
Wastani wa kiasi cha mauzo
2.41M
Kiasi cha mauzo ya hisa
2.10M
Juu kwa wiki 52
US$ 3.94
Chini kwa wiki 52
US$ 1.66
EPS
-US$ 0.62
Beta
2.09
Hisa za wawekezaji
154.34M
Idadi ya wafanyakazi
87
Fungua
US$ 1.90
Juu
US$ 1.94
Chini
US$ 1.82
Mtaji wa soko
281.67M
Wastani wa kiasi cha mauzo
2.41M
Kiasi cha mauzo ya hisa
2.10M
Juu kwa wiki 52
US$ 3.94
Chini kwa wiki 52
US$ 1.66
EPS
-US$ 0.62
Beta
2.09
Hisa za wawekezaji
154.34M
Idadi ya wafanyakazi
87
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
BigGo Finance
·
saa 6 zilizopita
New York Stocks Fall for Fourth Straight Session Ahead of Nvidia Earnings; Dow Plunges 1.6%
ChartMill
·
saa 7 zilizopita
S&P 500 After-Hours Gainers for Nov. 17, 2026
Fox Business
·
saa 9 zilizopita
S&P 500 decline driven by semiconductor confidence issues, says Scott Chronert
Traders Union
·
saa 4 zilizopita
S&P 500 rises 10 percent amid challenging backdrop, Nate Geraci notes
Wasifu
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Kuhusu Editas Medicine Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi87
LilianzishwaNov 2013
Makao makuu-
SektaHealth Care
Sekta-
Tovutieditasmedicine.com